Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations.

Last updated on 23-8-2019 by Anonymous (not verified)

Peer reviewed scientific article




Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidity and mortality worldwide. Several TB vaccine candidates are currently in clinical and preclinical development. They fall into two categories, the one of candidates designed as a replacement of the Bacille Calmette Guérin (BCG) to be administered to infants and the one of sub-unit vaccines designed as booster vaccines. The latter are designed as vaccines that will be administered to individuals already vaccinated with BCG (or in the future with a BCG replacement vaccine). In this review we provide up …

Associated health topics:

QR code

QR code for this page URL